Clinical trials: Werner Syndrome
Werner's Syndrome
Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome
OBJECTIVES: I. Assess the safety and efficacy of recombinant human insulin-like growth factor 1 in a patient with Werner's syndrome and osteoporosis.
- Trial name
- NCT00004815
- Testing
- growth hormone
- Volunteers
- 1 people
- Sponsor
- National Center for Research Resources (NCRR)